Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 5c, provides guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. PEP
5. T
6. CVS
7. UNH
8. TMUS
9. VZ
10. SPY

Go back to Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 5c, provides guidance

Vanda Pharmaceuticals (VNDA) PT Raised to $13 at Cantor Fitzgerald

August 1, 2024 6:35 AM EDT

Cantor Fitzgerald analyst Charles Duncan raised the price target on Vanda Pharmaceuticals (NASDAQ: VNDA) to $13.00 (from $11.00) while maintaining a Overweight rating.

The analyst comments "Overall, we see VNDA as a differentiated Neuro-Innovator with a broadening neuropsych portfolio that should garner investors' interest as... More